Pfizer-BioNTech COVID-19 Vaccine was NOT approved August 23, 2021

The News Release from the FDA on August 23, 2021 announced that the Pfizer-BioNTech COVID-19 Vaccine was approved. It was NOT! What was approved was a new product called Comirnaty.

They did not refer the application to the Vaccines and Related Biological Products Advisory Committee??

“We did not refer your application to the Vaccines and Related Biological Products Advisory Committee because our review of information submitted in your BLA, including the clinical study design and trial results, did not raise concerns or controversial issues that would have benefited from an advisory committee discussion.”

Why are they lying to us?

It is all about money and legal liabilities. It is also about them having protection from future trials based on the Nuremberg Code. The FDA states that there are legal differences between the Pfizer-BioNTech and Comirnaty COVID-19 Vaccines.

If the Pfizer Comirnaty product is the one that is licensed, why don’t we read much about it in news stories?

Most news stories since the end of August are about Pfizer-BioNTech COVID-19 Vaccine. Now the FDA has “approved” the Pfizer-BioNTech COVID-19 Vaccine for children 5-11 years old. Why are they still pushing the experimental product and not the approved Comirnaty product?

For Further Reading

Subscribe For Updates

Subscribe to my mailing list and get updates to your email inbox.

Thank you for subscribing.

Something went wrong.

By Henry Griner

As a Digital Online Consultant, I serve entrepreneurs who lead ministries, churches. non-profit organizations or local businesses. I build WordPress websites and provide consulting services. I do volunteer work in many areas including donating my time and resources to build websites for non-profit organizations. If you would like to Pay-It-Forward to help me, click on the Support My Work menu button.

One thought on “The FDA Does a Bait and Switch with COVID Shots”

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe For Updates

Subscribe to my mailing list and get updates to your email inbox.

Thank you for subscribing.

Something went wrong.